Liraglutide, sold under the brand names Victoza and Saxenda among others, is an anti-diabetic medication used to treat type 2 diabetes, and chronic obesity...
31 KB (2,666 words) - 11:03, 12 June 2024
Insulin degludec/liraglutide, sold under the brand name Xultophy, is a fixed-dose combination medication for the treatment of adults with type 2 diabetes...
7 KB (475 words) - 23:07, 17 April 2024
cardiovascular disease. Semaglutide and similar drugs, such as dulaglutide and liraglutide, have been used to treat binge eating disorder (BED), as they can successfully...
66 KB (5,418 words) - 02:41, 13 June 2024
dose compared to liraglutide in some of the measured parameters after ten weeks of daily intraperitoneal injections with liraglutide (2.5 or 25 nmol/kg)...
21 KB (1,918 words) - 15:23, 13 April 2024
Danish scientist and university professor. She led the development of liraglutide and semaglutide,[third-party source needed] two notable drugs approved...
15 KB (1,641 words) - 07:37, 2 June 2024
blood. With the exception of insulin, most GLP-1 receptor agonists (liraglutide, exenatide, and others), and pramlintide, all diabetes medications are...
49 KB (5,099 words) - 00:03, 17 May 2024
diabetes GLP-1 receptor agonists : albiglutide, dulaglutide, exenatide, liraglutide, lixisenatide, semaglutide, tirzepatide Dipeptidyl peptidase-4 Glucose-dependent...
26 KB (3,371 words) - 21:24, 10 June 2024
GLP-1 receptor agonists became popular for weight loss. The medications liraglutide, naltrexone/bupropion, orlistat, semaglutide, and tirzepatide are approved...
53 KB (5,009 words) - 17:54, 13 June 2024
S2CID 73313508. "Lilly's Once-Weekly Dulaglutide Shows Non-Inferiority to Liraglutide in Head-to-Head Phase III Trial for Type 2 Diabetes" (Press release)...
16 KB (1,512 words) - 06:23, 7 April 2024
A10AE54 Insulin glargine and lixisenatide A10AE56 Insulin degludec and liraglutide A10AF01 Insulin (human) A10BA01 Phenformin A10BA02 Metformin A10BA03...
6 KB (508 words) - 06:49, 20 December 2023
agonist Liraglutide compared with Colesevelam in reducing stool frequency in patients suffering from bile acid diarrhoea, suggesting Liraglutide as a new...
22 KB (2,535 words) - 03:11, 24 May 2024
medications beneficial for long-term use are: orlistat, lorcaserin, liraglutide, phentermine–topiramate, and naltrexone–bupropion. They result in weight...
175 KB (18,772 words) - 00:43, 6 June 2024
(liraglutide) that is in the same class as exenatide. The data available for exenatide showed less of a risk towards thyroid cancer than liraglutide,...
24 KB (2,087 words) - 16:42, 11 May 2024
Byetta and Bydureon, manufactured by AstraZeneca), approved in 2005/2012 liraglutide (Victoza for diabetes, Saxenda for obesity, manufactured by Novo Nordisk)...
36 KB (3,979 words) - 18:40, 8 June 2024
of obesity (as a short-term) under the brand name "Desoxyn". Nicotine Liraglutide as brand name Saxenda Semaglutide (brand name Ozempic/Wegovy) GLP-1 agonist...
17 KB (1,878 words) - 11:08, 23 May 2024
and several, including dulaglutide (Trulicity), exenatide (Byetta), liraglutide (Victoza), semaglutide (Ozempic, Wegovy and Rybelsus) and exenatide extended-release...
7 KB (757 words) - 23:21, 3 March 2024
insulin‡ Ultralente insulin‡ ultra-long-acting Insulin degludec# (+insulin aspart, +liraglutide) Insulin icodec† (+semaglutide) inhalable Exubera‡ Afrezza...
4 KB (262 words) - 03:35, 22 March 2024
insulin‡ Ultralente insulin‡ ultra-long-acting Insulin degludec# (+insulin aspart, +liraglutide) Insulin icodec† (+semaglutide) inhalable Exubera‡ Afrezza...
23 KB (2,538 words) - 04:18, 9 June 2024
Pharmaceuticals introduced a biosimilar variant of the anti-diabetic drug Liraglutide, marking a pioneering endeavor within the Indian pharmaceutical landscape...
11 KB (937 words) - 23:55, 6 June 2024
insulin‡ Ultralente insulin‡ ultra-long-acting Insulin degludec# (+insulin aspart, +liraglutide) Insulin icodec† (+semaglutide) inhalable Exubera‡ Afrezza...
16 KB (1,798 words) - 07:40, 1 February 2024
site which are more common under albiglutide than, for example, under liraglutide. The US approval lists the thyroid C cell cancers medullary thyroid carcinoma...
11 KB (1,096 words) - 06:20, 7 April 2024
claims-based assessment of the risk of pancreatitis and pancreatic cancer with liraglutide compared to other antidiabetic drugs". Diabetes, Obesity and Metabolism...
35 KB (3,196 words) - 14:36, 3 June 2024
insulinemia and fatty liver disease in mice, alone and in combination with liraglutide". Journal of Biological Chemistry. 296: 100807. doi:10.1016/j.jbc.2021...
5 KB (238 words) - 12:16, 30 April 2024
contraception due to the risk of teratogenic effects of the medication. Liraglutide and semaglutide are glucagon-like peptide-1 receptor agonists which are...
85 KB (10,254 words) - 16:10, 17 April 2024
insulin‡ Ultralente insulin‡ ultra-long-acting Insulin degludec# (+insulin aspart, +liraglutide) Insulin icodec† (+semaglutide) inhalable Exubera‡ Afrezza...
24 KB (1,890 words) - 05:07, 13 April 2024
cholangiopancreatography, D—drugs (commonly azathioprine, valproic acid, liraglutide). The differential diagnosis for pancreatitis includes but is not limited...
40 KB (3,958 words) - 20:41, 11 June 2024
insulin‡ Ultralente insulin‡ ultra-long-acting Insulin degludec# (+insulin aspart, +liraglutide) Insulin icodec† (+semaglutide) inhalable Exubera‡ Afrezza...
39 KB (3,481 words) - 21:56, 19 May 2024
insulin‡ Ultralente insulin‡ ultra-long-acting Insulin degludec# (+insulin aspart, +liraglutide) Insulin icodec† (+semaglutide) inhalable Exubera‡ Afrezza...
10 KB (781 words) - 19:33, 20 December 2023
insulin‡ Ultralente insulin‡ ultra-long-acting Insulin degludec# (+insulin aspart, +liraglutide) Insulin icodec† (+semaglutide) inhalable Exubera‡ Afrezza...
149 KB (14,257 words) - 05:35, 10 June 2024
lixisenatide albiglutide beinaglutide dulaglutide efpeglenatide langlenatide liraglutide PEG- Loxenatide semaglutide taspoglutide Ecnoglutide Utreglutide Glepaglutide...
33 KB (4,070 words) - 19:12, 15 May 2024